Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hills

Showing results (31-40 of 298) with videos related to

Pageof 30
Sort By:
Annals of Neurology|December 14, 2011
Atherosclerotic stroke in children? A public health red flagNancy K Hills, Heather J Fullerton
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2013
Intergenerational mutation rate does not equal long-term evolutionary substitution rateGillian C Gibb, Simon F K Hills
Journal of Evidence-Based Medicine|February 26, 2011
Balancing treatment allocations by clinician or center in randomized trials allows unacceptable levels of treatment predictionRobert K Hills, Richard Gray, Keith Wheatley
The New England Journal of Medicine|August 11, 2016
Assessment of Minimal Residual Disease in Standard-Risk AMLRobert K Hills, Adam Ivey, David Grimwade, et al.
Best Practice & Research. Clinical Haematology|June 8, 2014
Can we say farewell to monitoring minimal residual disease in acute promyelocytic leukaemia?David Grimwade, Jelena V Jovanovic, Robert K Hills
Leukemia Research|August 19, 2003
Corner cutting compromises clinical trials: the inherent problems with up-front randomisation and a common standard armR K Hills, S M Richards, K Wheatley
Blood Reviews|November 17, 2010
Independent prognostic variables in acute myeloid leukaemiaMatthew L Smith, Robert K Hills, David Grimwade
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2006
Problems with up-front randomization in clinical trialsKeith Wheatley, Robert K Hills, Alan K Burnett
Pharmacotherapy|April 29, 2020
Combining Antidepressants with β-Blockers: Evidence of a Clinically Significant CYP2D6 Drug InteractionJaekyu Shin, Nancy K Hills, Patrick R Finley
Neurology|August 22, 2014
Timing and number of minor infections as risk factors for childhood arterial ischemic strokeNancy K Hills, Stephen Sidney, Heather J Fullerton
Pageof 30

Showing results (31-40 of 298) with videos related to

Sort By:
Pageof 30
Annals of Neurology|December 14, 2011
Atherosclerotic stroke in children? A public health red flagNancy K Hills, Heather J Fullerton
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2013
Intergenerational mutation rate does not equal long-term evolutionary substitution rateGillian C Gibb, Simon F K Hills
Journal of Evidence-Based Medicine|February 26, 2011
Balancing treatment allocations by clinician or center in randomized trials allows unacceptable levels of treatment predictionRobert K Hills, Richard Gray, Keith Wheatley
The New England Journal of Medicine|August 11, 2016
Assessment of Minimal Residual Disease in Standard-Risk AMLRobert K Hills, Adam Ivey, David Grimwade, et al.
Best Practice & Research. Clinical Haematology|June 8, 2014
Can we say farewell to monitoring minimal residual disease in acute promyelocytic leukaemia?David Grimwade, Jelena V Jovanovic, Robert K Hills
Leukemia Research|August 19, 2003
Corner cutting compromises clinical trials: the inherent problems with up-front randomisation and a common standard armR K Hills, S M Richards, K Wheatley
Blood Reviews|November 17, 2010
Independent prognostic variables in acute myeloid leukaemiaMatthew L Smith, Robert K Hills, David Grimwade
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2006
Problems with up-front randomization in clinical trialsKeith Wheatley, Robert K Hills, Alan K Burnett
Pharmacotherapy|April 29, 2020
Combining Antidepressants with β-Blockers: Evidence of a Clinically Significant CYP2D6 Drug InteractionJaekyu Shin, Nancy K Hills, Patrick R Finley
Neurology|August 22, 2014
Timing and number of minor infections as risk factors for childhood arterial ischemic strokeNancy K Hills, Stephen Sidney, Heather J Fullerton
Pageof 30